Facebook Refers Trump Account Suspension to Oversight Board 

Facebook has referred its decision to indefinitely suspend former President Donald Trump from its platforms to an independent oversight board, as the company grapples with how to treat one of its highest profile users after his exit from public office.

Britain's IG Group to Buy U.S. Options Firm Tastytrade for $1 Billion 

The deal, which would substantially increase IG's presence in the U.S. market. is a bid to capitalize on the boom in options trading by small investors.

Lilly Antibody Drug Prevents Covid-19 in Nursing Homes, Study Finds 

The drugmaker plans to ask U.S. health regulators to expand bamlanivimab's use to protect nursing-home residents and staff from Covid-19.

Buying Airline Stocks Takes a Leap of Faith 

U.S. carriers are hoping that pent-up demand for leisure travel could be unleashed as soon as this summer, but the evidence isn't yet strong enough.

Mytheresa IPO Is Less Fashion-Forward Than It Looks 

The former owners of troubled department store Neiman Marcus have sold a stake in the online retailer at an eye-popping valuation, but its business model may need a makeover.

Travelers Profit Increases 50%, Fueled by Car-Insurance Unit 

The insurer benefited from fewer catastrophes than in the year-earlier period and premium increases in some lines of business sold to corporate customers.

Intel to Cap Off Difficult Year Ahead of New Chief 

The chip maker is expected to report record annual sales blemished by market-share losses and technical setbacks.

Starboard Seeks to Take Control of Corteva Board, Oust CEO 

Starboard Value is seeking to take control of agricultural giant Corteva's board and replace its chief executive, according to people familiar with the matter.

Bumble's Bet on Women Won't Pay Off Everywhere 

Women have fallen fast for Bumble's platform, but investors may want to take it slow.

Europeans Clash With Pfizer, BioNTech Over Vaccine Deliveries 

Tension is rising between European authorities and Pfizer and BioNTech after officials said the companies had unexpectedly cut their deliveries of Covid-19 vaccines and put their immunization schedules at risk.


(END) Dow Jones Newswires

January 21, 2021 13:00 ET (18:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.